Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy

University of Southern California

Status: Withdrawn

Conditions: Unspecified Adult Solid Tumor

Treatments: Device: Millimeter-Wave Holographic Imaging

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT03789773

0S-18-6 (Other Identifier)

P30CA014089 (U.S. NIH Grant/Contract)

NCI-2018-02994 (Registry Identifier)

Details and patient eligibility

About

This trial studies the quality of holographic mm-wave imaging in patients undergoing radiation therapy. Holographic mm-wave imaging is a common type of imaging used in airport body scanners that may be helpful in improving the efficiency and positioning of radiation oncology patients and their overall experience.

Full description

PRIMARY OBJECTIVES:

I. To obtain patient images in a clinical setting and assess their quality.

SECONDARY OBJECTIVES:

I. To assess the registration agreement through a voxel-voxel distance-to-agreement metric.

OUTLINE:

Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial computed tomography (CT) simulation.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients who are scheduled to receive either an optical or CBCT imaging scan as part of their treatment management.
• The study will be open to English and Spanish speaking participants.

Exclusion criteria

• Patients that are not scheduled for fluoroscopic or optical imaging as part of the normal course of radiotherapy.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Diagnostic (holographic mm-wave imaging)

Experimental group

Description:

Patients undergo holographic mm-wave imaging in radiotherapy treatment position after initial CT simulation.

Treatment:

Device: Millimeter-Wave Holographic Imaging